MFIC Announces Opening of Microfluidics Technology Center
News Jun 22, 2007
MFIC Corporation (MFIC) has announced the opening of the Microfluidics Technology Center, a research and discovery facility located at the MFIC company headquarters in Newton, MA.
“The Microfluidics Technology Center will house our highly-specialized research team, dedicated to advancing the formulation field by developing new applications for Microfluidics’ technology and pursuing groundbreaking work in the field of nanotechnology,” said Dr. Thomai Panagiotou, Vice President of Research and Development.
“We are very excited about the Center and believe it will serve as an innovation hub, playing a critical role in unlocking countless formulation solutions for our customers—including potentially life-saving drugs—that to date could not be formulated,” Panagiotou added.
The Microfluidics Technology Center will provide customers full access to the Company’s R&D engineers and complete product suite to prepare, characterize and optimize formulation samples. Engineers will also assist customers in improving their existing products through reformulation using high-shear Microfluidizer® materials processors.
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019